के सभी प्रकाशन Vaibhav Warade . पुणे , भारत

Publications

Catheter Securement Device Market | Global Market Synopsis & Forecast – 2027


Catheter Securement Device Market

Growing demand for catheter securement devices in minimally invasive surgeries and technological advancement is expected to register a CAGR of ~8.2% during the forecast period of 2021 to 2027

The global catheter securement device market is driven by several factors, such as increasing demand forcatheter securement devices used in surgeries, rising incidence, and prevalence ofchronic illness.Furthermore, rising R&D activities for catheter securement devices areprojected to drive the market in the forecast period.

Major market players such as 3M company, B. Braun Melsungen AG, C.R. Bard, Inc., ConvaTec Group plc, and Baxter International Inc.are dominating the global catheter securement device market. Theseprominent players are involved in strategic agreements, new product launches, innovations, and joint ventures to sustain their market positions.For instance, in May 2019, Dale Medical Products, Inc. (US) introduced the Hold-n-Place catheter securement device, which is soft, comfortable, and has a flexible design with no hard plastic parts. It provides complete antimicrobial protection.

Get a Sample Report @ https://www.marketresearchfuture.com/sample_request/9121

Major Key Players:

Some of the key players in the global catheter securement device market are 3M Company (US), B. Braun Melsungen AG (Germany), Baxter International, Inc. (US), C.R. Bard, Inc. (US), Centurion Medical Products (US), ConvaTec Group plc (UK), Merit Medical Systems, Inc. (US), Smiths Medical (US), TIDI Products, LLC (US), M.C. Johnson Company, Inc. (US), DeRoyal Industries, Inc. (US), Cardinal Health (US), BioDerm Inc. (US), Starboard Medical, Inc. (US), and Pepper Medical (US).

FREE SAMPLE

Segment Analysis

The global catheter securement device market has been segmented into product type, application, end user, and region.

By product type, the market has been segregated into arterial, central venous, peripheral, chest drainage tubes, abdominal drainage tubes, epidural, and all-site securement devices.

Central venous is further segmented intoperipherally inserted central catheter (PICC), subclavian, midlines, femoral, portal, and jugular.Peripheralis further segmented into foley, nasogastric tubes,endotracheal tubes,ventriculoperitoneal, and continuous nerve blocks. The abdominal drainage tubessegment is further segmented intopercutaneous endoscopic gastrostomy, jejunal, and umbilical. The peripheral securement devices segment held the majority share in 2020 due to the extensive use of peripheral securement devices for blood transfusions and the administration of intravenous fluids&other medications after surgery.

Based on application, the catheter securement device market is segmentedintocardiovascular,radiology, general surgery, urological, respiratory, and gastric&oropharyngeal.The cardiovascular segment held the largest share in 2020 due to the rising prevalence of cardiovascular disorders such asatrial septal defect, heart valve disease, and coronary artery diseaseacross the globe.

Based on end user, the catheter securement device market is segmented into hospitals & clinics, home healthcare, and diagnostic centers.The hospitals & clinics segment held the largest market share in 2020 due toalarge number of hospitals present across the globe anda vastnumber of surgical procedures performed across these facilities.

Access Full Report Details and Order this Premium Report @ https://www.marketresearchfuture.com/reports/catheter-securement-device-market-9121

Regional Analysis

The market has been divided, by region, into North America, Europe, Asia-Pacific, and the Rest of the World.

North America is likely to dominate thecatheter securement device market in 2020,owing to thehigh prevalence of chronic diseasesand the presence of major industry players across the region. In addition, a large number of foreign patients prefer surgical procedures to be conducted in the US due to the easyavailability of high-end advanced resources and well-established healthcare infrastructure. Furthermore, according to the Centers for Disease Control and Prevention (CDC), heart disease was the leading cause of death in the US from 2015 to 2020.Thus, the rising number of patients suffering from heart diseases in the USmay increase the demand forheart-related surgeries and procedures, which, in turn, is likely to increase the demandfor catheter securement devices.

Europe holds the second-largest position in the catheter securement device market due to the increased adoption of minimally invasive surgeries across the region. In addition, countries such as Germany, France, Italy, Spain, and the UK have a large number of aging population, supporting the growth of the catheter securement device market.

Asia-Pacific is anticipated to be the fastest-growing regional market during the forecast period due to increasing investment in healthcare infrastructure, improving healthcare facilities. High mortality rates due to chronic diseases such as heart diseases, respiratory diseases, urinary diseases, and diabetesare creating demand for catheter securement devices and driving the region's market growth.

The growth ofthe catheter securement device market in the Rest of the World is attributed to increasing public health awareness and government initiatives to bring more advanced technologies of catheter securement devicesinto the region.

Browse Related Reports:

https://www.marketresearchfuture.com/reports/new-born-screening-market-6561

https://www.marketresearchfuture.com/reports/cholesterol-test-market-8738

https://www.marketresearchfuture.com/reports/menopause-treatment-market-4579

About Market Research Future

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street, 5Th Floor,

New York, New York 10013

United States of America

+1 646 845 9312

Email: [email protected]

Show more
0
1

Global Artificial insemination Market 2022 Size, Share, Growth, Opportunities and forecast to 2027


Artificial insemination Market

Artificial insemination involves depositing sperm into the uterus. In vitro fertilization (IVF) involves extracting the patient's egg cells to be fertilized in a lab. The resultant embryo is then transferred to the uterus. The reimbursement of these techniques is interrelated. Artificial insemination costs hundreds of dollars, while IVF costs thousands. Most of the countries in North America and Europe have a high adoption of treatments related to fertility. The number of cycles of artificial insemination covered differs depending on the country.

Global Artificial Insemination Market is expected to register a CAGR of 8.56% during the forecast period and is expected to hit USD 3,409.75 Million by 2027.

The province of New Brunswick, Canada, allows individuals to claim up to 50 percent of eligible costs incurred for IVF or IUI and related drugs, up to a maximum of USD 5,000. In France, up to four cycles of ART in women up to the age of 45 are reimbursed, whereas The National Institute for Health and Care Excellence (UK) recommends support until 3 cycles. Belgium, Denmark, the Netherlands, and Slovenia are reputed for their most generous reimbursement policies in Europe, with almost full coverage for up to six cycles. IVF treatments are fully covered by Belgium, Denmark, and Slovenia states. From 2018, in vitro fertilization (IVF) and embryo transfer services and pharmaceuticals are fully financed by Estonian Health Insurance Fund (EHIF). A Policy Audit on Fertility by ESHRE and supported by Merck & Co. was published in 2017. It mentioned a wide range of treatment options are available in the Czech Republic, from Intrauterine Insemination (IUI) to surrogacy. The donor eggs and sperm and embryos are explicitly protected under Czech law, which recommends 100% coverage by mandatory health insurance for up to four IVF cycles and six IUI, for women aged 22-39 years of age. In France, IUI and IVF/ICSI are fully reimbursed for women under 43 years of age, including up to six IUIs (one IUI per menstruation cycle).

Get a Sample Report @ https://www.marketresearchfuture.com/sample_request/1218

Major Key Players:

MRFR recognizes the following companies as the Key Players in the global artificial insemination market— Vitrolife AB, Genea Limited, Rinovum Women's Health, LLC, Pride Angel, Hi-tech Solutions, Kitazato Corporation, Fujifilm Irvine Scientific, and Rocket Medical.

Segment Analysis

Global Artificial Insemination Market has been segmented based on Type and End User.

The market, based on type, has been segregated into intrauterine, intracervical, and Intratubal.

On the basis of end-user, the artificial insemination market is classified into hospitals & clinics, fertility centers, and home-based.

Access Full Report Details and Order this Premium Report @ https://www.marketresearchfuture.com/reports/artificial-insemination-market-1218

Regional Analysis

Global Artificial Insemination Market, based on region, has been divided into the Americas, Europe, Asia-Pacific, and the Middle East and Africa. The Americas accounted for a larger share of the global artificial insemination market. The large share is majorly attributed to the presence of major manufacturers, increasing adoption of assisted reproductive technologies, technological advancements, and high disposable income. Boost in the reimbursement scenario in the European region, rising government initiatives to promote family planning, an increasing number of patients facing difficulty conceiving, an increasing number of manufacturers, improving economies, high disposable income per individual, and increased healthcare spending are driving the growth of the market in this region. The Asia Pacific region is anticipated to grow at a lucrative CAGR over the forecast period. For instance, according to a study by Inito (India), a Bengaluru-based medical technology company, 27.5 million couples suffered from infertility and were actively seeking children. Also, at least 10-15% of married couples experienced fertility issues in 2019. Currently, most private and public health insurers do not include fertility procedures and treatments under their coverage plans. A research paper in Reproductive Biology and Endocrinology in 2015 assessed the use of various fertility treatments by surveying fertility specialists in France, Germany, Italy, Spain, the UK, the US, China, and Japan. The analysis reported that ART outcomes are varied by country, with the highest percentage of women facing fertility-related issues in the US and China. The availability of a large patient pool is expected to help propel the growth rate of the region.

Browse Related Reports:

https://www.marketresearchfuture.com/reports/microfluidic-devices-market-954

https://www.marketresearchfuture.com/reports/sleeping-bruxism-treatment-market-5422

https://www.marketresearchfuture.com/reports/new-born-screening-market-6561

About Market Research Future

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street, 5Th Floor,

New York, New York 10013

United States of America

+1 646 845 9312

Email: [email protected]

Show more
0
1

Remdesivir Market - Global Industry Growth and Forecast – 2027


Remdesivir Market

Remdesivir is an antiviral drug. FDA approved the remdesivir drug in April 2020 for the clinical trials for COVID 19 treatment. Studies have shown that around 46% of US patients have been recovered from COVID 19 quickly.

The growth of the global Remdesivir (COVID 19) market can be contributed to the growing need for rescue medication, including remdesivir drugs, due to the outbreak of COVID-19 globally. Furthermore, the rising geriatric population is also expected to fuel market growth during the forecast period. However, the availability of various substitutes for Remdesivir (COVID 19), are expected to restrain the growth of the global Remdesivir (COVID 19) market.

According to MRFR analysis, Global Remdesivir Market is expected to register a CAGR of 31.2% during the forecast period of 2020 to 2027 and reach USD 10,119.99 Million by 2027.

Gilead Sciences, Inc., Bright Gene, Hainan Haiyao, Cipla, Pfizer, Merck, Cayman Chemical, Kelun Pharma, Hunan Warrant Pharmaceutical, Dr. Reddy's Laboratories, and others are some of the major market leaders in Remdesivir. Organic strategies such as product launches, mergers, and collaborations are used by the companies operating on the market to boost their share. Gilead Sciences, Inc., for instance, has announced it will donate 1.5 million doses of the medication for compassionate use. The company has also started manufacturing liquid and freeze-dried ways to improve supplies. UK-based AstraZeneca has approached rival drug maker Gilead Sciences about a potential merger.

Get a Sample Report @ https://www.marketresearchfuture.com/sample_request/10141

Major Key Players:

Some of the key players in the global remdesivir (COVID 19) market are Gilead Sciences, Inc. (US), Mylan (US), Cipla (India), Hetero Labs (India), and Jubilant Life Sciences (India)

Segment Analysis

Global Remdesivir (COVID 19) market has been segmented based on the Dosage and Distribution Channel.

Based on the dosage, the global remdesivir (COVID 19) market has been segmented into 5mg, 10mg, 50mg, and 100mg. The 100 mg segment is expected to hold the largest market share owing to rise in COVID 19 and 100 mg is specifically used for older people and COVID 19 is affecting more in older people

On the basis of distribution channel, the market has been segmented into hospitals and drug stores. The hospitals are expected to hold a major market share owing to government regulation i.e. the drug can be given in the hospitals only.

Access Full Report Details and Order this Premium Report @ https://www.marketresearchfuture.com/reports/remdesivir-market-10141

Regional Analysis

The market has been divided, by region, into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The Americas region held the largest market in 2020, owing to the growing cases of COVID 19 in the region. The remdesivir (COVID 19) market in the Americas has further been branched into North America and Latin America, with the North American market divided into the US and Canada. The European remdesivir (COVID 19) market has been categorized as Western Europe and Eastern Europe. The Western European market has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe. The remdesivir (COVID 19) market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. Due to the increasing rate of COVID 19 cases, the market in Asia-Pacific is expected to be the fastest-growing. The remdesivir (COVID 19) market in the Middle East & Africa has been divided into the Middle East and Africa.

Browse Related Reports:

https://www.marketresearchfuture.com/reports/cardiac-rehabilitation-devices-market-2069

https://www.marketresearchfuture.com/reports/artificial-heart-market-7985

https://www.marketresearchfuture.com/reports/surgical-blades-market-8107

About Market Research Future

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street, 5Th Floor,

New York, New York 10013

United States of America

+1 646 845 9312

Email: [email protected]

Show more
0
1
Show more